- Home
- CHRS vs IMPP Comparison
CHRS vs IMPP Comparison
Compare CHRS & IMPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHRS | IMPP |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | United States | Greece |
| Employees | N/A | 49 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.8M | 228.8M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | CHRS | IMPP |
|---|---|---|
| Price | $1.52 | $4.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $5.51 | N/A |
| AVG Volume (30 Days) | ★ 839.0K | 483.5K |
| Earning Date | 05-07-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 472.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $73.08 | $51.79 |
| Revenue Next Year | $30.94 | $6.97 |
| P/E Ratio | ★ N/A | $3.68 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $2.90 |
| 52 Week High | $2.62 | $6.57 |
Technical Indicators
Market Signals| Indicator | CHRS | IMPP |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 45.74 |
| Support Level | $1.37 | $4.73 |
| Resistance Level | $1.75 | $5.26 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 67.31 | 25.35 |
Price Performance
Historical ComparisonAbout CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.